Results 161 to 170 of about 10,644 (258)

Immunogenicity and safety of AS03-adjuvanted A/Astrakhan/3212/2020 (H5N8)-like influenza vaccine in adults: Phase 1/2, observer-blinded, randomized trial. [PDF]

Hum Vaccin Immunother
Hastie A, Gupta V, Lese P, Moya J, Schoonbroodt S, Beudjekian S, Struyf F.   +6 more
europepmc   +1 more source

Preclinical evaluation of an mRNA vaccine developed from the first human isolate of bovine H5N1. [PDF]

Cell Rep Med
Li H, Huang M, Feng S, Li W, Wei D, Li X, Quan Y, Gu H, Jiang T, Liu Y, Lu J, Song W, Zhang X, Yang Y, Pan Q, Chen L, Yu J, Lou H, Zhang M, Wang Y, To KK, Jia W, Lin J, Zhang Q.   +23 more
europepmc   +1 more source

Algorithm-Optimized H5 Influenza mRNA Vaccine Induces Broad Immune Responses. [PDF]

Int J Mol Sci
Wang L, Peng Z, He C, Zhang J, Yu P, Huang W, Wang Y, Zhao C.   +7 more
europepmc   +1 more source

Evaluation of the plasma antioxidant activity in women with early pregnancy losses. [PDF]

J Biomed Res
Tishkova OG, Dikareva LV, Berberova NT, Polovinkina MA, Osipova VP.   +4 more
europepmc   +1 more source

Production and Immune Response Against Pandemic Influenza Candidate Vaccines as Preparedness Against the Circulating H5N1 Influenza Viruses. [PDF]

Vaccines (Basel)
Lee Ho P, Medina-Armenteros Y, Mendonça Munhoz Dati L, Cajado-Carvalho D, Savio Silva C, Fernandes Campos P, Abreu PAE, Tavares de Castro J, Tonolli PN, Fujimori M, Silveira Martins Rosa R, Palameta S, Edward Miller M, Sakihara VA, de Lima Valadares F, Lauretti Ferreira F, Pereira Carvalho Holanda B, Gonçalves de Macedo D, Comone P, de Souza Suffert Fogaça N, Bimbo A, Catanzaro De Moraes F, Queiroz de Andrade ST, Lage Ferreira H, Luiz Durigon E, Weis Arns C, George Kallás E, Apetito Akamatsu M, das Neves Oliveira R.   +28 more
europepmc   +1 more source

Receptor-binding specificity and antigenic properties of a genotype D1.1 A(H5N1) influenza virus isolated from a human. [PDF]

Emerg Microbes Infect
Kandeil A, Chopra P, Ray SD, Ghotekar BK, Ranadheera C, Jeevan T, Fabrizio T, Rubrum A, Boons GJ, Tompkins SM, Bastien N, Webby RJ.   +11 more
europepmc   +1 more source

Global dynamics of avian influenza: a twenty-year analysis of highly pathogenic viruses linking the Caspian Basin, Eurasia and Africa sectors (2005-2025). [PDF]

Front Cell Infect Microbiol
Gadzhiev A, Petherbridge G, Alekseev A, Mutashev B, Sharshov K, Sobolev I, Daudova M, Perkovskii M, Fereidouni S, Shestopalov A.   +9 more
europepmc   +1 more source

Unsymmetrical sulfoxides with sterically hindered catechol fragment: synthesis, structure, electrochemical properties, and antiradical activity. [PDF]

Beilstein J Org Chem
Burmistrova DA, Fokin VA, Demidov OP, Kiskin MA, Arsenyev MV, Poddel'sky AI, Berberova NT, Smolyaninov IV.   +7 more
europepmc   +1 more source

A Phase 1/2 Dose-Ranging Safety and Immunogenicity Study of mRNA-Based Candidate Pandemic Influenza Vaccines in Healthy Adults. [PDF]

Clin Infect Dis
Cosgrove CA, Avanesov A, Rust D, Osibajo S, Kang K, Leav B, ODYSSEY Study Group .   +6 more
europepmc   +1 more source

Molecular evidence of neuroinvasive Sindbis virus infection in humans: detection in cerebrospinal fluid by next generation sequencing. [PDF]

Emerg Microbes Infect
Cusi MG, Savellini GG, Cassol C, Nencioni C, Bernini L, Tacconi D, Alessandri G, Rizzo L, Anichini G, Smura T, Vapalahti O.   +10 more
europepmc   +1 more source